Trials / Completed
CompletedNCT07033455
A Trial of HRS-1893 in Healthy Volunteers
A Phase 1, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of HRS-1893 in Healthy Participants
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Atridia Pty Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety and PK characteristics of a single oral dose of HRS-1893 in healthy voluunters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1893 | Single dose of HRS-1893 orally administered |
Timeline
- Start date
- 2025-06-25
- Primary completion
- 2025-09-05
- Completion
- 2025-10-30
- First posted
- 2025-06-24
- Last updated
- 2025-11-18
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT07033455. Inclusion in this directory is not an endorsement.